Royalty Pharma plc (NASDAQ:RPRX) Q3 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma Third Quarter Earnings Conference Call.
Royalty Pharma Plc (RPRX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Viking Global Andreas Halvorsen | 12,094,021 | $342,139,854 | +2% | 1.24% |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 11,899,194 | $336,628,198 | +9% | 0.59% |
| 3. | Millennium Management Israel Englander | 4,341,505 | $122,821,176 | +85% | 0.05% |
| 4. | GMT Capital Thomas E. Claugus | 3,097,500 | $87,628,275 | +28% | 3.49% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 3,033,200 | $85,809,228 | +45% | 0.2% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.51 | 130,000 | Large Shareholder, Officer, Director | 600,000 | 2023-06-28 | Filing | |
| $32.78 | 45,000 | Large Shareholder, Officer, Director | 470,000 | 2023-06-13 | Filing | |
| $33.00 | 45,000 | Large Shareholder, Officer, Director | 425,000 | 2023-06-12 | Filing | |
| $32.25 | 150,000 | Large Shareholder, Officer, Director | 380,000 | 2023-05-24 | Filing | |
| $32.94 | 69,612 | Large Shareholder, Officer, Director | 230,000 | 2023-05-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.55 | 35,702 | Director | 20,099 | 2024-01-04 | Filing | |
| $27.79 | 199,098 | Director | 55,801 | 2024-01-03 | Filing | |
| $28.52 | 235,200 | Director | 254,899 | 2024-01-02 | Filing | |
| $28.04 | 65,803 | 2,477,520 | 2023-12-29 | Filing | ||
| $28.20 | 209,863 | 2,543,323 | 2023-12-28 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 46,354,266 | $1,302,091,425 | 0.11% | |
| 2. | 37,997,522 | $1,067,350,392 | 0.02% | |
| 3. | 31,583,929 | $887,192,558 | 0.06% | |
| 4. | 21,459,462 | $602,796,290 | 0.01% | |
| 5. | 17,590,450 | $494,115,741 | 0.4% |
News See All
10 Stocks with Biggest Upside Potential According to Hedge Funds
The US equities saw a strong move after the September jobs report exceeded the economists’ estimates.
10 Best Affordable Stocks To Buy Right Now
The stock market appears to be at a turning point. While major indexes are still hovering near record levels, there's been increased volatility this earnings season.
Jim Cramer on Royalty Pharma plc (NASDAQ:RPRX): It's Been a 'Bit of a Bust, I Feel Badly'
Jim Cramer in a latest program on CNBC said that the market has already priced in the expected positive comments from the Fed Chair Jerome Powell at the Jackson Hole event in Wyoming.
Jim Cramer’s Latest Lightning Round: Top 10 Stocks
Jim Cramer in a latest program on CNBC said that the market has already priced in the expected positive comments from the Fed Chair Jerome Powell at the Jackson Hole event in Wyoming.
10 Best Defensive Stocks To Buy Now
Defensive stocks tend to remain stable and less affected by economic downturns.
Royalty Pharma plc (NASDAQ:RPRX) Q2 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to Royalty Pharma Second Quarter Earnings Conference Call.
Should You Consider Adding Royalty Pharma plc (RPRX) to Your Portfolio?
Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Best Undervalued Stocks To Buy Now
In the prior couple of years, experts and analysts were worried about a recession in the US and their best-case scenario was a soft landing. Experts are still predicting the latter.
Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript
Royalty Pharma plc misses on earnings expectations. Reported EPS is $0.008 EPS, expectations were $0.96.
Billionaire Hedge Funds
